Alivus Life Sciences Ltd.

A fair growth of 16.90% in the revenue at Rs. 5953.63 millions was reported in the September 2023 quarter as compared to Rs. 5092.99 millions during year-ago period.Net profit stood at Rs. 1187.37  millions  compared to Rs. 1068.78 millions in the corresponding previous quarter,high by 11.10%.The company reported a good operating profit of 1724.53 millions compared to 1536.59 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202309	202209	% Var	202309	202209	% Var	202303	202203	% Var
Sales	5953.63	5092.99	16.90	11738.13	9991.69	17.48	21612.20	21232.14	1.79
Other Income	53.69	100.20	-46.42	72.20	195.13	-63.00	289.57	147.04	96.93
PBIDT	1724.53	1536.59	12.23	3674.65	3099.20	18.57	6712.50	6307.64	6.42
Interest	3.99	1.33	200.00	7.95	2.68	196.64	5.47	279.62	-98.04
PBDT	1720.54	1535.26	12.07	3666.70	3096.52	18.41	6707.03	6028.02	11.26
Depreciation	131.29	99.35	32.15	257.41	198.14	29.91	420.94	378.77	11.13
PBT	1589.25	1435.91	10.68	3409.29	2898.38	17.63	6286.09	5649.25	11.27
TAX	401.88	367.13	9.47	867.42	742.27	16.86	1616.48	1462.01	10.57
Deferred Tax	14.88	28.20	-47.23	44.43	41.05	8.23	110.37	85.74	28.73
PAT	1187.37	1068.78	11.10	2541.87	2156.11	17.89	4669.61	4187.24	11.52
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	245.05	0.00
PBIDTM(%)	28.97	30.17	-3.99	31.31	31.02	0.93	31.06	29.71	4.55